Free Trial

Mirum Pharmaceuticals (MIRM) SEC Filings & 10K Form

Mirum Pharmaceuticals logo
$43.48 -0.21 (-0.48%)
(As of 10:02 AM ET)

Recent Mirum Pharmaceuticals SEC Filings

DateFilerForm TypeView
11/15/2024
4:34 PM
Howe Jolanda (Reporting)
Mirum Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
11/14/2024
3:32 PM
Mirum Pharmaceuticals (Issuer)
Peetz Christopher (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
11/14/2024
3:34 PM
BJERKHOLT ERIC (Reporting)
Mirum Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
11/12/2024
10:44 AM
BlackRock, Inc. (Filed by)
Mirum Pharmaceuticals (Subject)
Form SC 13G/A
10/22/2024
5:06 PM
BlackRock, Inc. (Filed by)
Mirum Pharmaceuticals (Subject)
Form SC 13G/A
10/01/2024
3:39 PM
GREY MICHAEL G (Reporting)
Mirum Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
09/20/2024
3:39 PM
Heron Patrick J (Reporting)
Mirum Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
09/12/2024
3:18 PM
BJERKHOLT ERIC (Reporting)
Mirum Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
09/10/2024
4:04 PM
Heron Patrick J (Reporting)
Mirum Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
08/07/2024
3:11 PM
Mirum Pharmaceuticals (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
07/24/2024
4:32 PM
Mirum Pharmaceuticals (Issuer)
Peetz Christopher (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
07/10/2024
12:12 PM
JANUS HENDERSON GROUP PLC (Filed by)
Mirum Pharmaceuticals (Subject)
Form SC 13G
07/03/2024
5:19 PM
Howe Jolanda (Reporting)
Mirum Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
07/01/2024
4:35 PM
Longpre Lara (Reporting)
Mirum Pharmaceuticals (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
06/25/2024
4:15 PM
Mirum Pharmaceuticals (Issuer)
Vig Pamela (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/24/2024
3:31 PM
Mirum Pharmaceuticals (Subject)
Vig Pamela (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
06/17/2024
7:03 AM
Mirum Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/07/2024
5:19 PM
Fairey William (Reporting)
Mirum Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/07/2024
5:20 PM
Mirum Pharmaceuticals (Issuer)
Ramasastry Saira (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/07/2024
5:21 PM
Fischer Laurent (Reporting)
Mirum Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/07/2024
5:22 PM
Heron Patrick J (Reporting)
Mirum Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/07/2024
5:22 PM
Brege Laura (Reporting)
Mirum Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/07/2024
5:23 PM
Cardon Lon (Reporting)
Mirum Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/07/2024
5:24 PM
Mirum Pharmaceuticals (Issuer)
Walbert Timothy P (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/07/2024
5:25 PM
GREY MICHAEL G (Reporting)
Mirum Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/06/2024
3:38 PM
Mirum Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/31/2024
4:24 PM
Mirum Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/16/2024
3:30 PM
Mirum Pharmaceuticals (Issuer)
Vig Pamela (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/16/2024
3:30 PM
Mirum Pharmaceuticals (Issuer)
Peetz Christopher (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/16/2024
3:30 PM
BJERKHOLT ERIC (Reporting)
Mirum Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
05/08/2024
3:16 PM
Mirum Pharmaceuticals (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
04/23/2024
3:20 PM
Mirum Pharmaceuticals (Filer)
Form DEF 14A
04/23/2024
3:21 PM
Mirum Pharmaceuticals (Filer)
Form DEFA14A
03/27/2024
7:47 PM
BJERKHOLT ERIC (Reporting)
Mirum Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/25/2024
4:41 PM
Mirum Pharmaceuticals (Issuer)
Radovich Peter (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/18/2024
4:44 PM
Mirum Pharmaceuticals (Issuer)
Vig Pamela (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/18/2024
4:46 PM
Mirum Pharmaceuticals (Issuer)
Radovich Peter (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/18/2024
4:34 PM
BJERKHOLT ERIC (Reporting)
Mirum Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/18/2024
4:37 PM
Mirum Pharmaceuticals (Issuer)
Peetz Christopher (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/18/2024
4:40 PM
Longpre Lara (Reporting)
Mirum Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/15/2024
4:32 PM
Mirum Pharmaceuticals (Filer)
Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans  
Tesla Execs are Freaking Out (Ad)

It’s so revolutionary that tech giants like Microsoft, Amazon, and NVIDIA are all lining up to get their hands on it. And Elon Musk has completely restructured Tesla to chase this opportunity. This is a once-in-a-lifetime opportunity that you don’t want to miss.

03/15/2024
4:03 PM
Mirum Pharmaceuticals (Filer)
Form 10-K
Annual report pursuant to Section 13 or 15(d)  
02/28/2024
3:05 PM
Mirum Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/14/2024
11:49 AM
EVENTIDE ASSET MANAGEMENT, LLC (Filed by)
Mirum Pharmaceuticals (Subject)
Form SC 13G/A
02/05/2024
8:04 PM
Mirum Pharmaceuticals (Issuer)
Peetz Christopher (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/05/2024
8:05 PM
Mirum Pharmaceuticals (Issuer)
Radovich Peter (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/05/2024
8:10 PM
Longpre Lara (Reporting)
Mirum Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/05/2024
8:12 PM
Mirum Pharmaceuticals (Issuer)
Vig Pamela (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/02/2024
8:28 PM
Howe Jolanda (Reporting)
Mirum Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/31/2024
1:08 PM
BlackRock Inc. (Filed by)
Mirum Pharmaceuticals (Subject)
Form SC 13G
01/25/2024
6:10 PM
Mirum Pharmaceuticals (Issuer)
Peetz Christopher (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/25/2024
6:10 PM
Mirum Pharmaceuticals (Issuer)
Radovich Peter (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/25/2024
6:10 PM
Howe Jolanda (Reporting)
Mirum Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/25/2024
6:10 PM
BJERKHOLT ERIC (Reporting)
Mirum Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/25/2024
6:10 PM
Longpre Lara (Reporting)
Mirum Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/25/2024
6:10 PM
Mirum Pharmaceuticals (Issuer)
Vig Pamela (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/18/2024
6:39 PM
Mirum Pharmaceuticals (Issuer)
Quan Joanne (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
01/18/2024
6:42 PM
Mirum Pharmaceuticals (Issuer)
Quan Joanne (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/09/2024
7:21 PM
Mirum Pharmaceuticals (Issuer)
Vig Pamela (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/09/2024
7:25 PM
Longpre Lara (Reporting)
Mirum Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/09/2024
7:28 PM
Mirum Pharmaceuticals (Issuer)
Radovich Peter (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/09/2024
7:09 PM
Howe Jolanda (Reporting)
Mirum Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/09/2024
7:12 PM
Mirum Pharmaceuticals (Issuer)
Peetz Christopher (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/08/2024
7:30 AM
Mirum Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
12/06/2023
4:16 PM
Howe Jolanda (Reporting)
Mirum Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
(Data available from 1/1/2016 forward)


Related Companies and Tools


This page (NASDAQ:MIRM) was last updated on 11/21/2024 by MarketBeat.com Staff
From Our Partners